Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.22.4
Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share            
Net earnings, including noncontrolling interest $ 50,005 $ 89,734 $ 72,059 $ 68,981 $ 139,739 $ 141,040
Less net earnings (loss) attributable to noncontrolling interest     (8,114)   179 (8,748)
Net earnings attributable to Bio-Techne 50,005   80,173   139,560 149,788
Income allocated to participating securities (10)   (34)   (35) (70)
Income available to common shareholders $ 49,995   $ 80,139   $ 139,525 $ 149,718
Weighted-average shares outstanding - basic (in shares) 157,011   157,240   156,887 156,808
Earnings per share - basic (in shares) $ 0.32   $ 0.51   $ 0.89 $ 0.95
Income available to common shareholders $ 49,995   $ 80,139   $ 139,525 $ 149,718
Dilutive effect of stock options and restricted stock units (in shares) 4,739   7,588   4,879 7,828
Weighted-average common shares outstanding - diluted (in shares) 161,750   164,828   161,766 164,636
Earnings per share - diluted (in shares) $ 0.31   $ 0.49   $ 0.86 $ 0.91